Travoprost [clinicaltrials_resource:4e899a81da1b55d9b7927482d02d18f8]
Study of TRAVATAN in Subjects With Iris Pigmentation Changes [clinicaltrials:NCT00047554]A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [clinicaltrials:NCT00051142]clinicaltrials:NCT00051168A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma [clinicaltrials:NCT00051181]Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan [clinicaltrials:NCT00121147]A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00293761]A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00293787]A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00293800]Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients [clinicaltrials:NCT00308945]A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00311389]24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination [clinicaltrials:NCT00331240]A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00333125]Results of Mass Switch From Latanoprost to Travoprost [clinicaltrials:NCT00347126]Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004% [clinicaltrials:NCT00347802]Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension [clinicaltrials:NCT00348023]Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00372827]clinicaltrials:NCT00440011Effects of Travoprost on Neovascular Glaucoma [clinicaltrials:NCT00441181]24-hour Intraocular Pressure Control With Travoprost/Timolol Fixed Combination Versus Travoprost [clinicaltrials:NCT00444184]Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy [clinicaltrials:NCT00444665]A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension [clinicaltrials:NCT00465803]Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers [clinicaltrials:NCT00468988]clinicaltrials:NCT00471068A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension [clinicaltrials:NCT00471380]clinicaltrials:NCT00508469Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav [clinicaltrials:NCT00519753]IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00527501]A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00527592]clinicaltrials:NCT00539526Study of Patient Use and Perception of the Travatan Dosing Aid [clinicaltrials:NCT00626067]Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost [clinicaltrials:NCT00637130]Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00670033]A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00672997]clinicaltrials:NCT00676637Glaucoma Adherence Study, Spain [clinicaltrials:NCT00680329]clinicaltrials:NCT00690794The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye [clinicaltrials:NCT00705757]clinicaltrials:NCT00708422Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG) [clinicaltrials:NCT00716742]Value of an Intervention to Enhance Adherence in Glaucoma Patients [clinicaltrials:NCT00756184]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Travoprost [clinicaltrials_resource:4e899a81da1b55d9b7927482d02d18f8]
Bio2RDF identifier
4e899a81da1b55d9b7927482d02d18f8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4e899a81da1b55d9b7927482d02d18f8
identifier
clinicaltrials_resource:4e899a81da1b55d9b7927482d02d18f8
title
Travoprost
@en
type
label
Travoprost [clinicaltrials_resource:4e899a81da1b55d9b7927482d02d18f8]
@en